UnitedHealthcare Community Plan of Tennessee says its TMS guideline considers treatment proven and medically necessary for qualifying adults with major depressive disorder.
Tennessee TMS level of care guidance
UnitedHealthcare Community Plan of Tennessee publishes Level of Care Guidelines for transcranial magnetic stimulation, or TMS. According to UnitedHealthcare Community Plan of Tennessee, the guideline addresses when TMS is considered proven and medically necessary under the conditions described in the document.
UnitedHealthcare Community Plan of Tennessee states that its guideline applies to individuals who are 18 or older and have a confirmed diagnosis of major depressive disorder. The source describes TMS as proven and medically necessary for those individuals when the guideline’s conditions are met.
Treatment-resistance requirement
According to UnitedHealthcare Community Plan of Tennessee, one condition in its TMS guideline is resistance to treatment with psychopharmacologic agents. The guideline says this resistance is evidenced by a lack of clinically significant response to trials of medication.
The source does not describe TMS as medically necessary for every person with major depressive disorder. Instead, UnitedHealthcare Community Plan of Tennessee ties its medical-necessity language to adults with a confirmed diagnosis who meet the conditions listed in the guideline, including the medication-trial requirement.
Benefits can differ by member
UnitedHealthcare Community Plan of Tennessee says member-specific benefits supersede the TMS guideline. This means the source identifies the guideline as informational material rather than the controlling description of an individual member’s benefits.
The document also says it is not medical advice. UnitedHealthcare Community Plan of Tennessee presents the guideline as a statement of its level-of-care criteria for TMS, including its description of age, diagnosis, and medication-response conditions.
For people reviewing the document, the source’s central points are that TMS is addressed for adults age 18 or older, that a confirmed major depressive disorder diagnosis is identified, and that the guideline includes a treatment-resistance condition involving psychopharmacologic medication trials.
What this means for Tennessee patients
UnitedHealthcare Community Plan of Tennessee’s guideline may be useful general information for Tennessee residents seeking to understand how one plan describes TMS level-of-care criteria. People looking for treatment locally can use the directory, which lists 97 published clinics in Tennessee, while considering their own member-specific benefits.
This is general information, not medical advice.
More Tennessee reporting on access & coverage.
This report is educational and is not medical advice. Coverage, availability and eligibility can change; verify details with the named source or your care team.